Edition:
United Kingdom

Adocia reports topline results of Biochaperone Glucagon Phase 1 study


Monday, 20 Nov 2017 

Nov 20 (Reuters) - ADOCIA SA ::ADOCIA REPORTS TOPLINE RESULTS OF BIOCHAPERONE® GLUCAGON PHASE 1 STUDY.‍BIOCHAPERONE GLUCAGON WAS FOUND TO BE SAFE AND WELL TOLERATED IN PEOPLE WITH TYPE 1 DIABETES​.‍BIOCHAPERONE GLUCAGON DEMONSTRATED EFFICACY IN RESCUING PARTICIPANTS FROM MEDICALLY INDUCED HYPOGLYCEMIA IN MEDIAN TIME OF 11 MINS​. 

Related Company News

Company Quote

11.42
0.12 +1.06%
13 Sep 2019